Skip to content Skip to footer
|

Feds Call for More Scrutiny of Nursing Home Errors Involving Blood Thinner

Inspectors are being asked to pay greater attention following analysis showing mistakes resulting in injuries and deaths.

(Image: Nursing home via Shutterstock)

Also see: Popular Blood Thinner Causing Deaths and Injuries at Nursing Homes

The federal government is asking health inspectors nationwide to be on the lookout for errors by nursing homes in managing the blood thinner Coumadin, including those that lead to patient hospitalizations and deaths.

In a memo sent last month to state health departments, the Centers for Medicare and Medicaid Services cited a report by ProPublica and The Washington Post that focused on the harm caused by homes’ failure to manage the drug.

The analysis of government inspection reports found that, between 2011 and 2014, at least 165 nursing home residents were hospitalized or died after errors involving Coumadin or its generic version, warfarin. In some cases, homes gave residents too much of the drug, which caused internal bleeding. In other cases, they gave residents too little, leading to blood clots and strokes.

ProPublica’s findings “highlighted the adverse effects of poor Coumadin management for our beneficiaries and nursing home stakeholders,” Thomas Hamilton, director of CMS’ survey and certification group, said in a written response to questions from ProPublica. “We wanted the public to have confidence that CMS is aware of this as well as other high risk medications.”

In its July 17 memo, CMS – the federal agency that regulates nursing homes – also told state health departments that inspect nursing homes on its behalf about a new tool for identifying and reducing medication errors. The tool, developed with the Agency for Healthcare Research and Quality, is designed to help determine whether nursing homes are taking adequate steps to prevent mistakes and whether they respond appropriately if they occur.

Although Coumadin has clear benefits and is life-saving for those taking the right dose, a number of peer-reviewed studies suggest that it is can be dangerous if not closely monitored. A 2007 study in The American Journal of Medicine estimated that nursing home residents suffer 34,000 fatal, life-threatening or serious events each year related to the drug.

Last year, the Department of Health and Human Services identified Coumadin and other anticoagulants as a category of drugs frequently implicated in “adverse drug events” and called on government agencies to work on solutions.

“Adverse events related to high risk medications can have devastating effects to nursing home residents,” the July 17 memo said. “We are very concerned about the prevalence of adverse events involving such medications.”

Despite such evidence, Coumadin deaths and hospitalizations have drawn far less attention than other problems in nursing homes, including the use of antipsychotic medications. Such medications can put elderly patients into a stupor and increase their risk of falls.

Officials with the American Health Care Association, a trade group for the nursing home industry, said that they want to know whether the government intends to use its new medication error tool as a means to help nursing homes improve or a way to punish them.

“This document is written to detect stuff after the fact, to catch folks if they’ve done something wrong,” said David Gifford, the group’s senior vice president of quality and regulatory affairs. “I’m a little worried about that. We’ll wait and see.”

About 1 in 6 of the nation’s 1.3 million nursing home residents take an anticoagulant, according to federal data from earlier this year; the majority are believed to be on Coumadin or its generic.

Newer anticoagulants such as Eliquis, Pradaxa and Xarelto have entered the market in recent years and, in some ways, are easier to use than Coumadin. Patients taking these drugs don’t need regular blood tests and don’t have to avoid certain foods.

But unlike Coumadin, the effects of which can be reversed with vitamin K, there’s currently no antidote if patients taking the newer drugs begin bleeding uncontrollably.

Janet Snipes, administrator at Holly Heights Care Center in Denver, recently discussed her home’s approach to preventing Coumadin errors on a national call with other nursing home leaders. Nursing supervisors in every unit monitor a document that tracks each patient on Coumadin, their dose, the rate at which their blood clots, their ideal clotting rate, when tests are ordered, whether they have been performed, and whether doctors have been identified.

“If there’s a mistake, we want a system in place so that it’s caught,” Snipes said. “People get busy and they forget things but if you have a system, then it gets caught.”

This story was co-published with The Washington Post.

We’re not backing down in the face of Trump’s threats.

As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.

Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.

As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.

At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.

Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.

You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.